Ligand-regulated Peptide Aptamers that Inhibit the 5′-AMP-activated Protein Kinase

Journal of Molecular Biology

Volumn 365, Issue 4, 2007, Pages 945-957

  Miller, Russell A ^a   Binkowski, Brock F ^a   Belshaw, Peter J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

AMPK; ligand regulated peptide aptamers; peptide aptamer; pseudosubstrate; substrate inhibition

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; APTAMER; HYBRID PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; LIGAND REGULATED PEPTIDE; RAPAMYCIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL ENERGY; ENERGY CONSUMPTION; ENERGY YIELD; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME SUBSTRATE; ENZYME SUBUNIT; HOMEOSTASIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

EID: 33845772308     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.07.035     Document Type: Article

References (59)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
2. Gossen M., and Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu. Rev. Genet. 36 (2002) 153-173
3. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
4. Schreiber S.L. The small-molecule approach to biology. Chem. Eng. News 81 (2003) 51-61
5. Clackson T. Controlling mammalian gene expression with small molecules. Curr. Opin. Chem. Biol. 1 (1997) 210-218
6. Liberles S.D., Diver S.T., Austin D.J., and Schreiber S.L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl Acad. Sci. USA 94 (1997) 7825-7830
7. Mootz H.D., Blum E.S., Tyszkiewicz A.B., and Muir T.W. Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. J. Am. Chem. Soc. 125 (2003) 10561-10569
8. Rivera V.M., Wang X.R., Wardwell S., Courage N.L., Volchuk A., and Keenan T. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287 (2000) 826-830
9. Sakamoto K.M., Kim K.B., Kumagai A., Mercurio F., Crews C.M., and Deshaies R.J. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 98 (2001) 8554-8559
10. Spencer D.M., Wandless T.J., Schreiber S.L., and Crabtree G.R. Controlling signal transduction with synthetic ligands. Science 262 (1993) 1019-1024
11. Belshaw P.J., Schoepfer J.G., Liu K.Q., Morrison K.L., and Schreiber S.L. Rational design of orthogonal receptor-ligand combinations. Ange. Chemie-Int. Ed. Eng. 34 (1995) 2129-2132
12. Bishop A.C., Buzko O., and Shokat K.M. Magic bullets for protein kinases. Trends Cell Biol. 11 (2001) 167-172
13. Koh J.T. Engineering selectivity and discrimination into ligand-receptor interfaces. Chem. Biol. 9 (2002) 17-23
14. Maly D.J., Allen J.A., and Shokat K.M. A mechanism-based cross-linker for the identification of kinase-substrate pairs. J. Am. Chem. Soc. 126 (2004) 9160-9161
15. Shi Y.H., and Koh J.T. Selective regulation of gene expression by an orthogonal estrogen receptor-ligand pair created by polar-group exchange. Chem. Biol. 8 (2001) 501-510
16. Binkowski B.F., Miller R.A., and Belshaw P.J. Ligand-regulated peptides: a general approach for modulating protein-peptide interactions with small molecules. Chem. Biol. 12 (2005) 847-855
17. Buskirk A.R., Landrigan A., and Liu D.R. Engineering a ligand-dependent RNA transcriptional activator. Chem. Biol. 11 (2004) 1157-1163
18. Buskirk A.R., and Liu D.R. Creating small-molecule-dependent switches to modulate biological functions. Chem. Biol. 12 (2005) 151-161
19. Mandal M., and Breaker R.R. Gene regulation by riboswitches. Nature Rev. Mol. Cell. Biol. 5 (2004) 451-463
20. Vuyisich M., and Beal P.A. Controlling protein activity with ligand-regulated RNA aptamers. Chem. Biol. 9 (2002) 907-913
21. Werstuck G., and Green M.R. Controlling gene expression in living cells through small molecule-RNA interactions. Science 282 (1998) 296-298
22. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., et al. A protein interaction map of Drosophila melanogaster. Science 302 (2003) 1727-1736
23. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., and Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl Acad. Sci. USA 98 (2001) 4569-4574
24. Uetz P., Giot L., Cagney G., Mansfield T.A., Judson R.S., Knight J.R., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403 (2000) 623-627
25. Colas P., Cohen B., Jessen T., Grishina I., McCoy J., and Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380 (1996) 548-550
26. Cohen B.A., Colas P., and Brent R. An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc. Natl Acad. Sci. USA 95 (1998) 14272-14277
27. Fabbrizio E., Le Cam L., Polanowska J., Kaczorek M., Lamb N., Brent R., and Sardet C. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene 18 (1999) 4357-4363
28. Kurtz S.E., Esposito K., Tang W., and Menzel R. Inhibition of an activated Ras protein with genetically selected peptide aptamers. Biotechnol. Bioeng. 82 (2003) 38-46
29. Butz K., Denk C., Ullmann A., Scheffner M., and Hoppe-Seyler F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl Acad. Sci. USA 97 (2000) 6693-6697
30. Abedi M.R., Caponigro G., and Kamb A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucl. Acids Res. 26 (1998) 623-630
31. Norman T.C., Smith D.L., Sorger P.K., Drees B.L., O'Rourke S.M., Hughes T.R., et al. Genetic selection of peptide inhibitors of biological pathways. Science 285 (1999) 591-595
32. Woodman R., Yeh J.T., Laurenson S., and Ko Ferrigno P. Design and validation of a neutral protein scaffold for the presentation of peptide aptamers. J. Mol. Biol. 352 (2005) 1118-1133
33. Binz H.K., Amstutz P., and Pluckthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nature Biotechnol. 23 (2005) 1257-1268
34. Hitoshi Y., Gururaja T., Pearsall D.M., Lang W., Sharma P., Huang B., et al. Cellular localization and antiproliferative effect of peptides discovered from a functional screen of a retrovirally delivered random peptide library. Chem. Biol. 10 (2003) 975-987
35. Choi J.W., Chen J., Schreiber S.L., and Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 273 (1996) 239-242
36. Hardie D.G., and Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23 (2001) 1112-1119
37. Sim A.T., and Hardie D.G. The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Letters 233 (1988) 294-298
38. Carling D., Clarke P.R., Zammit V.A., and Hardie D.G. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186 (1989) 129-136
39. Jorgensen S.B., Nielsen J.N., Birk J.B., Olsen G.S., Viollet B., Andreelli F., et al. The alpha2-5′AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53 (2004) 3074-3081
40. Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277 (2002) 23977-23980
41. Marsin A.S., Bouzin C., Bertrand L., and Hue L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 277 (2002) 30778-30783
42. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., and Winder W.W. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48 (1999) 1667-1671
43. Cheung P.C., Salt I.P., Davies S.P., Hardie D.G., and Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346 (2000) 659-669
44. Iseli T.J., Walter M., van Denderen B.J., Katsis F., Witters L.A., Kemp B.E., et al. AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270). J. Biol. Chem. 280 (2005) 13395-13400
45. Davies S.P., Carling D., and Hardie D.G. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur. J. Biochem. 186 (1989) 123-128
46. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67 (1998) 821-855
47. Adams J., Chen Z.P., Van Denderen B.J., Morton C.J., Parker M.W., Witters L.A., et al. Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci. 13 (2004) 155-165
48. Rudolph M.J., Amodeo G.A., Bai Y., and Tong L. Crystal structure of the protein kinase domain of yeast AMP-activated protein kinase Snf1. Biochem. Biophys. Res. Commun. 337 (2005) 1224-1228
49. Banaszynski L.A., Liu C.W., and Wandless T.J. Characterization of the FKBP.rapamycin.FRB ternary complex. J. Am. Chem. Soc. 127 (2005) 4715-4721
50. Dale S., Wilson W.A., Edelman A.M., and Hardie D.G. Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Letters 361 (1995) 191-195
51. Wilson D.S., and Szostak J.W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68 (1999) 611-647
52. Scott J.W., Norman D.G., Hawley S.A., Kontogiannis L., and Hardie D.G. Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate. J. Mol. Biol. 317 (2002) 309-323
53. Henin N., and Vincent M.F. G. Van den Berghe, Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim. Biophys. Acta 1290 (1996) 197-203
54. Ferdinand W. The interpretation of non-hyperbolic rate curves for two-substrate enzymes. A possible mechanism for phosphofructokinase. Biochem. J. 98 (1966) 278-283
55. McCafferty D.G., Lessard I.A., and Walsh C.T. Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX. Biochemistry 36 (1997) 10498-10505
56. Vartanian J.P., Henry M., and Wain-Hobson S. Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions. Nucl. Acids Res. 24 (1996) 2627-2631
57. Woods R.A., and Gietz R.D. High-efficiency transformation of plasmid DNA into yeast. Methods Mol. Biol. 177 (2001) 85-97
58. Hardie D.G., Salt I.P., and Davies S.P. Analysis of the role of the AMP-activated protein kinase in the response to cellular stress. Methods Mol. Biol. 99 (2000) 63-74
59. Weekes J., Ball K.L., Caudwell F.B., and Hardie D.G. Specificity determinants for the AMP-activated protein kinase and its plant homologue analysed using synthetic peptides. FEBS Letters 334 (1993) 335-339